TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Ame Bioscience AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
12,137
|
3,847
|
14,166 |
| Financial expenses |
14
|
15
|
68 |
| Earnings before taxes |
2,451
|
720
|
2,910 |
| Total assets |
6,391
|
3,510
|
5,723 |
| Current assets |
6,391
|
3,507
|
5,718 |
| Current liabilities |
2,335
|
821
|
772 |
| Equity capital |
4,056
|
2,689
|
4,951 |
| - share capital |
63
|
66
|
71 |
| Employees (average) |
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
63.5%
|
76.6%
|
86.5% |
| Turnover per employee |
12,137
|
3,847 | |
| Profit as a percentage of turnover |
20.2%
|
18.7%
|
20.5% |
| Return on assets (ROA) |
38.6%
|
20.9%
|
52.0% |
| Current ratio |
273.7%
|
427.2%
|
740.7% |
| Return on equity (ROE) |
60.4%
|
26.8%
|
58.8% |
| Change turnover |
8,483
|
-9,448
|
-3,120 |
| Change turnover % |
232%
|
-71%
|
-18% |
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.